Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists

• Main Authors: Anna Volerman (Author), Alison Pelczar (Author), Rena Conti (Author), Christina Ciaccio (Author), Kao-Ping Chua (Author)
• Format: Book
• Published: BMC, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Oral albuterol has worse efficacy and side effects compared with inhaled albuterol, and thus its use has been discouraged for decades. Drug inclusion or exclusion on formularies have been associated with reductions in low-value care. This study examines dispensing of oral albuter...